Geode Capital Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
968,541
-1,182,851
| -55% | -$368K | ﹤0.01% | 3730 |
|
|
2025
Q1 | $1.05M | Buy |
2,151,392
+67,250
| +3% | +$32.9K | ﹤0.01% | 3292 |
|
|
2024
Q4 | $1.78M | Sell |
2,084,142
-7,527
| -0.4% | -$6.45K | ﹤0.01% | 3172 |
|
|
2024
Q3 | $17.8M | Sell |
2,091,669
-7,146
| -0.3% | -$60.8K | ﹤0.01% | 2039 |
|
|
2024
Q2 | $9.8M | Buy |
2,098,815
+1,494,387
| +247% | +$6.98M | ﹤0.01% | 2336 |
|
|
2024
Q1 | $4.11M | Buy |
604,428
+26,757
| +5% | +$182K | ﹤0.01% | 2801 |
|
|
2023
Q4 | $1.94M | Buy |
577,671
+134,199
| +30% | +$450K | ﹤0.01% | 3111 |
|
|
2023
Q3 | $1.1M | Buy |
443,472
+2,967
| +0.7% | +$7.39K | ﹤0.01% | 3279 |
|
|
2023
Q2 | $564K | Buy |
440,505
+79,427
| +22% | +$102K | ﹤0.01% | 3595 |
|
|
2023
Q1 | $293K | Hold |
361,078
| – | – | ﹤0.01% | 3870 |
|
|
2022
Q4 | $274K | Buy |
361,078
+29,012
| +9% | +$22K | ﹤0.01% | 3932 |
|
|
2022
Q3 | $308K | Buy |
332,066
+169,623
| +104% | +$157K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $154K | Sell |
162,443
-125,487
| -44% | -$119K | ﹤0.01% | 4403 |
|
|
2022
Q1 | $607K | Sell |
287,930
-15,313
| -5% | -$32.3K | ﹤0.01% | 3845 |
|
|
2021
Q4 | $2.71M | Sell |
303,243
-12,851
| -4% | -$115K | ﹤0.01% | 3220 |
|
|
2021
Q3 | $5.25M | Buy |
316,094
+25,174
| +9% | +$418K | ﹤0.01% | 2886 |
|
|
2021
Q2 | $6.05M | Buy |
290,920
+34,953
| +14% | +$726K | ﹤0.01% | 2785 |
|
|
2021
Q1 | $4.8M | Buy |
255,967
+66,479
| +35% | +$1.25M | ﹤0.01% | 2807 |
|
|
2020
Q4 | $4.17M | Buy |
189,488
+19,660
| +12% | +$433K | ﹤0.01% | 2697 |
|
|
2020
Q3 | $3.53M | Buy |
169,828
+3,908
| +2% | +$81.1K | ﹤0.01% | 2585 |
|
|
2020
Q2 | $6M | Buy |
165,920
+39,224
| +31% | +$1.42M | ﹤0.01% | 2225 |
|
|
2020
Q1 | $4.14M | Buy |
126,696
+58,946
| +87% | +$1.93M | ﹤0.01% | 2247 |
|
|
2019
Q4 | $1.85M | Buy |
67,750
+43,634
| +181% | +$1.19M | ﹤0.01% | 3040 |
|
|
2019
Q3 | $265K | Buy |
+24,116
| New | +$265K | ﹤0.01% | 3681 |
|